Trials / Completed
CompletedNCT00058968
A Study for the Treatment of Painful Diabetic Neuropathy
Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 660 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Detailed description
The protocol will assess the efficacy and safety of duloxetine. It will also look at how duloxetine affects quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine hydrochloride | |
| DRUG | placebo |
Timeline
- Start date
- 2002-10-01
- Completion
- 2005-03-01
- First posted
- 2003-04-16
- Last updated
- 2007-05-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00058968. Inclusion in this directory is not an endorsement.